Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
Claritev Corporation

Claritev Corporation (CTEV) Stock Overview

Explore Claritev Corporation’s financial performance, market position, analyst ratings, and future outlook.

CTEV●NYSE
HealthcareMedical - Healthcare Information Services
$42.22
$6.90(19.54%)
U.S. Market opens in 3h 9m

Claritev Corporation (CTEV)

Meyka AI Score

Z

Key Financials

Market Cap719.4M
P/E Ratio-2.27
EPS (TTM)$-17.01
ROE1.40%
Fundamental Analysis

AI Price Forecasts

1 Month$50.66
3 Months$49.79
1 Year Target$28.38

CTEV Stock Analysis & Investment Overview (NYSE)

Our AI-powered analysis of Claritev Corporation (NYSE: CTEV) gives investors deep insight into how the stock performs on the NYSE exchange, its growth potential, and its market positioning. With a Meyka AI Score of B+, Claritev Corporation's NYSE-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of CTEV on the NYSE shows an RSI of 78.01, suggesting the stock is in a an overbought condition. Our forecasting models predict a 12-month price target of $28.38 for the NYSE listing.

Key metrics behind Claritev Corporation's NYSE-traded stock include a P/E ratio of -2.27 and a market capitalization of 719.4M. Combined with our AI analysis, these give both institutional and retail investors a clear view of CTEV on the NYSE.

Price Performance (NYSE: CTEV)

1-Day Change
19.48%
5-Day Change
44.82%
1-Month Change
41.42%
3-Month Change
53.009%
6-Month Change
83.56%
Year-to-Date (YTD) Change
-1.29%
1-Year Change
-40.04%
3-Year Change
44.52%
5-Year Change
44.52%
All-Time (Max) Change
44.52%

Contact Information

https://www.claritev.com
(212) 780-2000
7900 Tysons One Place, McLean, VA, 22102

Company Facts

30,000 Employees
IPO DateApr 3, 2020
CountryUS
Actively Trading

Frequently Asked Questions